A summary of the work of the NCRI Brain Group during the year 2019-20.…
NCRI Bladder and Renal Group Annual Report 2019-20
'A summary of the work of the NCRI Bladder & Renal Group during the year 2019-20.…
Demystifying PPI in cancer research – webinar Q&A
'Following the recent NCRI virtual session titled ‘Demystifying patient and public involvement in cancer research’ we have published this Q&A…
Cancer/Covid-19 Research Summit
'The pandemic has highlighted the importance of research and has made it clear that it is an integral part of a well-functioning healthcare system. There are numerous lessons to learn about how cancer-related research is conducted and how findings are translated into practice to aid crisis responses.…
NCRI CTRad How to write a good lay summary
'The lay summary, or lay abstract, is an integral part of funding applications. NCRI CTRad’s consumer members looked at a…
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer
'CONCORDE is a platform study seeking to establish the toxicity profiles of multiple novel radiosensitisers targeting DNA repair proteins in…
Patient & Public Involvement (PPI) opportunities across the NCRI Partnership
'A summary of the opportunities for patients, carers and other affected by cancer from across the NCRI Partnership.…
NCRI Annual Review 2019-20
'A review of NCRI’s key activities and accounts for the financial year 2019-20…
Radiotherapy Clinical Trials Roles and Responsibilities RTTQA Group and CTUs
'A standardised approach to partnership working between the National RTTQA group and the Clinical Trials Units (CTUs) supports efficient development…
Heavy charged particle beam therapy and related new radiotherapy technologies: The clinical potential, physics and technical developments required to deliver benefit for patients with cancer
'Report of a meeting to consider how the UK should address new technologies for RT, especially the use of heavier charged particles such as helium and carbon and new modes of delivery such as FLASH and spatially fractionated radiotherapy (SFRT), which took place in 2019. The meeting included contribution from NCRI CTRad members.…
Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines
'The Global Quality Assurance of Radiation Therapy Clinical Trials Harmonization Group (GHG) is a collaborative group of RT QA Groups…
Comparing Proton to Photon Radiotherapy Plans: UK Consensus Guidance for Reporting Under Uncertainty for Clinical Trials
'This report aims to provide guidance for those engaged in UK clinical trials comparing protons and photons. This guidance is…